IGLON5 and supranuclear palsy, progressive, 1: Sabater et al. showed that only one of thirty-two patients with PSP tested positive for anti-IgLON5 antibodies [26], suggesting that it is impractical to measure IgLON5 antibodies in all patients clinically diagnosed with PSP.